Intellectual Property Protection for Plants in the United States Anne Marie Grünberg Supervisory Patent Examiner Art Units 1661 and 1638.

Slides:



Advertisements
Similar presentations
IMPACT OF PLANT VARIETY PROTECTION John Calvert United States Patent And Trademark Office.
Advertisements

Enablement and Written Description Issues in Utility Plant Applications Gary Benzion, Ph.D. Acting Supervisory Patent Examiner AU 1638.
September 21, 2006 DePaul University, Chicago, IL APLF- DePaul University College of Law 2006 Symposium on Intellectual Property Law.
Filing for a United States Patent “Helpful Hints” U.S. Patent and Trademark Office.
INTELLECTUAL PROPERTY
Proteomics Examination Yvonne (Bonnie) Eyler Technology Center 1600 Art Unit 1646 (703)
Utility and Written Description Steve Kunin Deputy Commissioner for Patent Examination Policy Esther Kepplinger Deputy Commissioner for Patent Operations.
Common Claim Breadth Issues in Plant- Related Applications Anne Marie Grünberg Supervisory Patent Examiner Art Units 1661 and 1638.
1 Homology Language Brian R. Stanton Quality Assurance Specialist Technology Center 1600 U.S. Patent and Trademark Office (703)
Industrial Property the Patent system
INTRODUCTION TO PATENT RIGHTS The Business of Intellectual Property
1 35 USC 112, 1 st paragraph enablement Enablement Practice in TC 1600 Deborah Reynolds, SPE
MONSANTO v. SCHMEISER The U.S. Perspective 78 TH IPIC ANNUAL MEETING October 14 – 16, 2004 Bruce C. Haas.
Proteomics and “Orphan” Receptors Yvonne (Bonnie) Eyler Technology Center 1600 Art Unit 1646 (703)
India’s Plant Protection Issues Srividhya Ragavan Associate Professor of Law University of Oklahoma Law Center.
“REACH-THROUGH CLAIMS”
1 Biotechnology Partnership Meeting April 17, 2001 James Martinell Senior Level Examiner Technology Center 1600.
Intellectual Property March 4, 2015 Don Keach Director, Intellectual Property Development and Technology Transfer Office Copyright University of Kentucky.
Determination of Obviousness Practice Under the Genus-Species Guidelines and In re Ochiai; In re Brouwer Sreeni Padmanabhan & James Wilson Supervisory.
1 Single Nucleotide Polymorphisms (SNP) Gary Jones SPE, Technology Center 1600 (703)
Animals and Transgenesis Peter Paras, Jr.. 2 Overview Introduction — Definitions Types of Transgenic Animals — How they are made Examination of Transgenic.
Protecting Our Food But Leaving Our Harvest? Srividhya Ragavan University of Oklahoma Law Center.
1 OVERVIEW OF PATENTS: TRIPS and US PATENT EXAMINATION United States Patent and Trademark Office Global Intellectual Property Academy Patent, Trademark,
Restriction Practice for Genus Claims Species Claims Linking Claims and Markush Claims Julie Burke QAS/PM TC1600.
Biotechnology/Chemical/Pharmaceutical Customer Partnership Topic: Biotechnology/Chemical/Pharmaceutical Customer Partnership Topic: Examining Issues When.
Mark D. Janis Professor of Law University of Iowa College of Law.
Patent Overview by Jeff Woller. Why have Patents? Patents make some people rich – but, does that seem like something the government should protect? Do.
Issues in Patenting Proteins Jon P Weber, SPE 1657.
Patents 101 April 1, 2002 And now, for something new, useful and not obvious.
Examination Issues: Immunology Yvonne (Bonnie) Eyler Quality Assurance Specialist Technology Center 1600 USPTO (571)
1 Unity of Invention: Biotech Examples TC1600 Special Program Examiner Julie Burke (571)
1 Intellectual Property Protection for Plants in the United States Anne Marie Grünberg Supervisory Patent Examiner Art Units 1661 and 1638.
© 2010 Hodgson Russ LLP IEEE Southern Area Entrepreneur’s Day Overview Of The Patent Process R. Kent Roberts Hodgson Russ LLP (716)
Stem Cells Peter Paras, Jr.. 2 Overview Introduction — Definitions Types of Stem Cells — Origin Examination of Stem Cell Claims — Statutes — Sample Claims.
Patent Protection Around the World & at the USPTO
1 ANTICIPATION BY INHERENCY IN PRIOR ART James O. Wilson Supervisory Patent Examiner Technology Center 1600 USPTO (571)
Broadening the Scope of the Claims in Gene Therapy Applications Deborah Reynolds Detailee, TCPS
1 John Calvert Supervisory Patent Examiner
Biotech Inventions in Latin America Argentina Ignacio Sánchez Echagüe Marval, O’Farrell & Mairal.
Restriction & Double Patenting Mojdeh Bahar, J.D., M.A., CLP Chief, Cancer Branch Office of Technology Transfer National Institutes of Health U.S. Department.
1 Patent Law in the Age of IoT The Landscape Has Shifted. Are You Prepared? 1 Jeffrey A. Miller, Esq.
Patent Law Presented by: Walker & Mann, LLP Walker & Mann, LLP 9421 Haven Ave., Suite 200 Rancho Cucamonga, Ca Office.
© 2011 Barnes & Thornburg LLP. All Rights Reserved. This page, and all information on it, is the property of Barnes & Thornburg LLP which may not be reproduced,
Overcoming Prior Art References Non-Enabling Prior Art References Gary Kunz SPE Art Unit 1616.
Josiah Hernandez Patentability Requirements. Useful Having utilitarian or commercial value Novel No one else has done it before If someone has done it.
Session 6 : An Introduction to the TRIPS Agreement UPOV, 1978 and 1991 and WIPO- Administered Treaties.
1 Written Description Analysis and Capon v. Eshhar Jeffrey Siew Supervisory Patent Examiner AU 1645 USPTO (571)
Hamre, Schumann, Mueller & Larson, P.C U.S. Patent Claims By James A. Larson.
Patentability of Reach-Through Claims Brian R. Stanton Practice Specialist Technology Center 1600 (703)
New Sections 102 & 103 (b) Conditions for Patentability- (1) IN GENERAL- Section 102 of title 35, United States Code, is amended to read as follows: -`Sec.
Patentability Considerations in the 3-D Structure Arts Patentability Considerations in the 3-D Structure Arts Michael P. Woodward Supervisory Patent Examiner.
Trilateral Project WM4 Report on comparative study on Examination Practice Relating to Single Nucleotide Polymorphisms (SNPs) and Haplotypes. Linda S.
1 Demystifying the Examination of Stem Cell-Related Inventions Remy Yucel, Ph.D. Supervisory Patent Examiner Technology Center 1600 United States Patent.
Vector Claims in Gene Therapy Applications: In vivo vs. In vitro Utilities Deborah Reynolds SPE GAU
How to Claim your Biotech- Based Invention Deborah Reynolds Detailee, TCPS
STT2073 Plant Breeding and Improvement Intellectual Properties.
Examination Practice in Applications Presenting “Reach-Through Claims” George Elliott Practice Specialist Technology Center 1600
© 2008 International Intellectual Property June 16, 2009 Class 2 Introduction to Patents.
Double Patenting Deborah Reynolds SPE Art Unit 1632 Detailee, TC1600 Practice Specialist
International Aspects of Plant Variety Protection Srividhya Ragavan University of Oklahoma Law Center.
1 Utility Guidelines, Homology Claims and Anti-Sense Molecule Claims Drew Hissong, Ph.D. dhissong*sughrue.com Sughrue Mion, PLLC
BLW 360 – January 27, 2015 Jonathan LA Phillips
Patents 101 March 28, 2006 And now, for something new, useful and not obvious.
Patents 101 March 28, 2006 And now, for something new, useful and not obvious.
Plant Biotechnology and Plant Breeder’s Rights :
Stem Cells Peter Paras, Jr.
What You Didn’t Know That You Didn’t Know About Patents
Examination Practice in Applications Presenting “Reach-Through Claims”
Examination Issues: Immunology
TRIPS Art. 27.3(b) and Agriculture
Presentation transcript:

Intellectual Property Protection for Plants in the United States Anne Marie Grünberg Supervisory Patent Examiner Art Units 1661 and 1638

Three Types of Protection Plant Patent Act, 1930 35 U.S.C. §§ 161-164 Plant Variety Protection Act, 1970, 1994 7 U.S.C. §§ 2321 et seq. Utility Patent to a Plant, 1980 35 U.S.C. §§ 111 (101, 102, 103, 112)

Legal History Plant Patent Act of 1930 Plant Variety Protection, 1970 Held asexually propagated plants excluding tubers, patentable Plant Variety Protection, 1970 In the U.S., protection afforded to sexually propagated plants, including tubers Diamond v. Chakrabarty, 447 U.S. 303 (1980) Held living things were indeed patentable Ex Parte Hibberd, 227 USPQ 443 (PTO Bd. Pat. App. & Int. 1985) Ruled that seeds, plant tissue cultures, and the plant itself are patentable subject matter under the utility patent statute J.E.M. Ag Supply, Inc. v. Pioneer Hi-Bred International, Inc., 534 U.S. 124, 60 USPQ2d 1865 (2001) Held newly developed plant breeds fall within the scope of §101, and neither the PPA or PVPA limits this coverage

What Protection is the Best? Depends on the business model May have one or all three May have trade secrets May lease plants/seeds Depends on what type of plant Sexually propagated, asexually propagated, depositable, tuber Depends on how much protection one desires Broader vs. narrower protection Plant, plant parts, methods of breeding, etc Depends on how much money one has Cost of filing Burden of proving distinctiveness Maintenance fees

Comparisons Plant Patents Plant Variety Protection Plant Utility Patents Protection The plant and its clones The plant and its clones, or plant and its homozygous seed The plant, methods of making, methods of using, methods of breeding, etc Type of plant Asexually reproduced plants, excluding edible tubers Sexually reproduced plants, edible tubers Any kind of plant that can be deposited Cost Starting at ~$1900 for small corporations, fees a la carte, no maintenance fees $5,150, burden on applicant to show distinctiveness, no maintenance fees Starting at ~$1300 for small corporations, fees a la carte, up to $7560 maintenance fees, possible deposit fees Advantages Least expensive “Softer” system, giving back to the community, no maintenance fees Broad coverage possible, burden on office to show not in conformance with the statutes

Utility v. Plant Patents An invention may support both a utility patent and a plant patent, so long as the subject matter protected by the two patents is not identical.

Utility v. Plant Patents Utility Patent- may be useful where invention is not limited to a particular variety or where method claims are desired Plant Patent- may be useful where it is difficult to meet the written description or enablement requirements of a utility patent

Plant Patent Act First protection of its kind worldwide - 1930 Relaxed 35 USC § 112, first requirement Applies to asexually reproduced plants (not including edible tuber propagated plants) 20 year term from date of filing Right to exclude others from making, using, selling, offering for sale and importing the plant, or any of its parts Protects a single plant and asexual progeny Total 19,712 plant patents

Art Unit 1661- Plant Patents (PLTs) 1 Expert examiner 3 Primary examiners 2 Assistant examiners 1 hybrid classifier/examiner Total = 7 examiners

Plant Patent Trends

Right to Priority MPEP1613 Right of Priority Based upon Application for Plant Breeder's Rights Pursuant to 35 U.S.C. 119(f), an application for a patent may rely upon an application for plant breeder's rights filed in a WTO member country (or in a foreign UPOV Contracting Party) for priority under 35 U.S.C. 119(a) through (c).

Plant Patent Act 35 U.S.C. 161 states: “Whoever invents or discovers and asexually reproduces any distinct and new variety of plant, including cultivated sports, mutants, hybrids, and newly found seedlings, other than a tuber propagated plant or a plant found in an uncultivated state, may obtain a patent therefor…”

Plant Patent Representative Claim A Petunia plant substantially as described and illustrated in the specification herein.

Quick Examination Overview PALM inventor search, terminal disclaimer Oath/declaration indicates asexually reproduced and if found, found in a cultivated area (37 CFR 1.162) Color chart/dictionary Comparison to parents, other known variety Description as complete as is reasonably possible A single claim in a particular format, must say “as described and illustrated”, must be drawn to entire plant Title drawn to plant Denomination Color drawings No unwarranted advertising, laudatory expressions

Quick Examination Overview continued Novelty In re Elsner Obviousness Radiation Colchicine Known plant with a known transgene

Requirements for Patentability Plant is new and distinct from other known varieties (35 U.S.C. 102, 103) Plant description as complete as is reasonably possible (35 U.S.C. 112, relaxed enablement requirement) Plant has been asexually propagated If “discovered,” plant was not found in an uncultivated state Plants discovered in the wild are excluded

Patentability May be Negated by: Lack of novelty Sale or public use of the plant in the U.S. more than 1 year prior to filing for U.S. patent Description of the plant in a printed publication, combined with public availability (anywhere) more than 1 year prior to filing for U.S. patent (In re Elsner 03-1569 (Fed. Cir. Aug 16, 2004)) Obviousness in view of the prior art Edible tuber propagated plant Description not as complete as is reasonably possible

Plant Variety Protection Act (PVPA) Administered by U.S. Department of Agriculture (USDA) Enacted in 1970, Amended in 1994 Plant must be New, Distinct, Uniform and Stable In U.S. applies only to sexually reproduced plants and edible tuber propagated plants 20-25 year protection from date of grant Exclude others from selling, offering for sale, multiplying, conditioning, importing, exporting and stocking the variety Breeder’s exemption, farmer’s exemption

Requirement for PVP New has not been sold or otherwise disposed of for purposes of exploitation for more than one year in the United States, or more than four years in any foreign jurisdiction (six years for trees and vines). Distinct clearly distinguishable from any other publicly known variety. Distinctness may be based on morphological, physiological, or other characteristics, including commercially valuable characteristics.

Requirement for PVP Uniform any variations are describable, predictable, and commercially acceptable. Stable the variety, when reproduced, will remain unchanged with regard to its essential and distinctive characteristics within a reasonable degree of commercial reliability.

Art Unit 1638- Plant Utility Patents 2 Senior examiners 10 Primary examiners 5 Assistant examiners Total = 17 examiners

Utility Patent Technology neutral Traditional breeding, transgenics 20 year protection from date of filing Right to exclude others from making, using, selling, offering for sale, and importing the patented plant in the granting territory Possible to protect a class of varieties with a specific trait, plant parts and methods of producing or using plant varieties

Agronomic Objectives of Plant Utility Patents Disease and insect resistance Drought and salt tolerance Herbicide resistance Improvement of fruit and flower quality Modification of fatty acid and oil composition Increases in amino acids and nutrition Improvement of sugars and carbohydrates Altered morphological phenotype Male sterility Phytoremediation and heavy metal tolerance Production of mammalian peptides and vaccines

Commercial Agricultural Products Overview

Growth of Genetically Modified Plants (GMP) 1996 - 17,000 km2 2004 – 809,000 km2 Soybean (63%) Maize (19%) Cotton (13%) Canola (5%) 2008 114 m hectares across 23 countries http://www.guardian.co.uk/environment/2008/feb/13/gmcrops.food 4 countries grow 99% of the GMP United States (68%) Argentina (22%) Canada (6%) China (3%) http://en.wikipedia.org/wiki/Genetically_modified_food

Plant Utility Patent Claims - Products Plants, Plant organs or tissue, Pollen, Ovules , Tissue or cell culture, Seeds Isolated plant polynucleotides and polypeptides Isolated plant regulatory elements (e.g. promoter, transcriptional elements) Expression cassettes or vectors Transgenic plants having a novel phenotype Products produced from transgenic plants

Plant Utility Patent Claims - Methods Methods of breeding novel/nonobvious plants using traditional methods Methods of molecular plant breeding Methods of producing a transgenic plant having a novel phenotype Novel plant transformation methods Methods of plant cell and tissue culture

Plant Utility Patent Representative Claims Claim 1. Seed of plant variety NN deposited as ATCC Accession No. _____. Claim 2. A plant grown from the seed of Claim 1. Claim 3. An isolated DNA encoding protein X. Claim 4. A method of making a transgenic plant having phenotype Y comprising transforming a plant with said DNA of Claim 3. Claim 5. A transgenic plant produced by the method of Claim 4.

Restriction Practice Claim 1. A soybean plant 37691, representative seed of said soybean cultivar having been deposited under ATCC Accession Number ____. Claim 2. A method for producing a soybean seed comprising crossing soybean plants and harvesting the resultant soybean seed, wherein at least one soybean plant is the soybean plant of claim 1. Claim 3. Oil derived from the seed of claim 1. Claim 4. A composition comprising soybean meal of the plant of claim 1.

35 USC §101 Non-Statutory Product of nature The “use” of Product of nature Isolated, operably linked, heterologous Specific, Substantial, Credible utility MAS (marker assisted selection)

Examples of 35 USC §101 issues Claim 1. A method of breeding wheat plants by evaluating SSR markers selected from table 1 and associating the correlation between yield and a marker defined by the polymorphic loci of table 1 in a breeding population. Non-statutory; not tied to a particular machine or apparatus, and does not transform a particular article to a different state or thing Claim 2. A method of breeding wheat plants as described in claim 1 wherein a wheat plant determined to have a change in a biochemical pathway is crossed with another wheat plant having a change and selecting progeny having said change. Lacks specific, substantial, and credible utility Followed by 35 USC §112, first Claim 3. A plant transformed with gene X or progeny of said plant. Product of nature

Anticipation: 35 USC § 102 Does the prior art teach a plant variety with the same characteristics? Does the prior art teach an isolated DNA as claimed? Does the prior art teach a method of making a transgenic plant comprising the isolated DNA as claimed? Largely dependent on the breadth of the claims

Examples of 35 USC §102 issues Claim 1. A striped tomato comprising: a fruit having a red background color; and at least one dark stripe associated with the fruit. Claim 101. An F2 hybrid derived from the plant of claim 1. Claim 1. An isolated promoter comprising: (a) a nucleotide sequence having SEQ ID No. 1 (b) a nucleotide sequence having a deletion, substitution or addition of one or more nucleotides from SEQ ID No. 1, or (c) a nucleotide sequence hybridizing under stringent conditions with SEQ ID No. 1.

Non-Obviousness 35 U.S.C. § 103 Are the characteristics of the claimed plant variety obvious over a prior art variety when grown under different conditions? Are the characteristics obvious morphological variants? Is the claimed DNA suggested by the prior art? If so, is there motivation to produce a transgenic plant comprising the DNA? Is there an expectation of success in obtaining a transgenic plant with phenotype Y?

Examples of 35 USC §103 issues Claim 1. Seed of soybean variety X, representative seed having been deposited under ATCC Accession No. ____. Note that variety x appears to be identical to variety W with the exception of resistance to a herbicide for which there are known resistance transgenes. This information may be in a Requirement for Information under 37 CFR 105. Claim 1. A genetically modified plant cell having increased activity A that has been transformed with the nucleotide sequence having Seq ID No. 1. Note that the nucleotide sequence, although novel, codes for a known protein having the same function Or the nucleotide sequence may differ from a known sequence but it was isolated from the same organism

Written Description 35 USC § 112, 1st Paragraph The specification shall contain a written description of the invention and of the manner and process of making and using it, in such full, clear, concise, and exact terms . . . any person skilled in the art to which it pertains . . . to make and use the same . . .

General Principles Basic inquiry: Can one skilled in the art reasonably conclude that the inventor was in possession of the claimed invention at the time the application was filed? No new matter may be added to the specification or claims The written description requirement is separate and distinct from the enablement requirement.

Written Description 35 USC § 112, 1st Paragraph How many DNAs (species) of the claimed genus are described? Are the species that are described representative of the claimed genus? Does Applicant describe a structural feature(s) unique to the claimed genus? Should generally include structural as well as functional claim language. Is the phenotype of the transgenic plant described? Is the genus of genes, recited or implied, responsible for conferring the claimed phenotype adequately described?

Examples of written description issues Claim 1. A pepper plant having fruits that are purple in coloration. Claim 1. A transgenic plant having a polynucleotide sequence that is 90% identical to SEQ ID No. 1.

Enablement 35 USC § 112, 1st Paragraph The specification shall contain a written description of the invention and of the manner and process of making and using it, in such full, clear, concise, and exact terms . . . any person skilled in the art to which it pertains . . . to make and use the same . . .

Enablement 35 USC § 112, 1st Paragraph Basic Inquiry: Can one skilled in the art make and use the invention without undue experimentation

Enablement 35 USC § 112, 1st Paragraph Has Applicant taught how to use the claimed plant variety, i.e. its agronomically useful phenotypic characteristics? Has Applicant taught how to use the claimed DNA? Has Applicant taught isolated DNAs? How many DNAs has Applicant isolated? Has Applicant provided specific guidance for isolation of other functionally related DNAs, including structurally unrelated DNAs? Should generally include structural as well as functional claim language.

Enablement 35 USC § 112, 1st Paragraph If the DNA is not enabled throughout the scope of the claim, the method of making a transgenic plant is not enabled throughout the scope of the claim. Has Applicant provided guidance for making a transgenic plant having phenotype Y? Have related genes resulted in phenotype Y upon expression in plants?  

Examples of Enablement Issues Claim 1. A transgenic plant having a polynucleotide sequence that is 85% identical to SEQ ID No. 1 wherein the plant exhibits a particular phenotype associated with the sequence. Claim 1. A method of making any mutant in any species by suppressing the expression of an xyz homologous gene in a plant. Claim 1. A method to confer disease resistance to a plant, comprising transforming the plant with an insecticidal gene.

Definiteness 35 USC § 112, 2nd Paragraph The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.

Definiteness 35 USC § 112, 2nd Paragraph Lack of antecedent basis Metes and bounds not defined Lack of clarity Terminology contrary to art-recognized definitions Lacking an essential step

Examples of Indefiniteness Claim 1. A method of making a transformed plant comprising: transforming a plant cell with gene x. Lacks essential step Claim 1. A plant comprising gene X. Claim 2. The tomato plant of claim1, wherein gene X is suppressed Lacks antecedent basis for tomato plant Claim 1. A method of transforming a tree, comprising: transforming a corn cell with gene X, and regenerating a whole corn plant from the transformed cell. Contrary to art-recognized definitions as corn is not a tree. Claim 1. A method of transforming a plant cell by culturing said plant cell with Agrobacterium for 1 minute to 7 days, preferably 30 minutes to 3 days, more preferably 4 hours to one day, for example 8 hours and 7 minutes. Metes and bounds not clearly set forth

Utility v. Plant Patents Requirement or Attribute Utility Patent (35 U.S.C. 111) Plant Patent (35 U.S.C. 161) Generic claim or protection possible Yes No – patent covers a single plant and its clones Method claims permitted No Number and format of claims limited Yes – one claim of prescribed format

Utility v. Plant Patents Requirement or Attribute Utility Patent (35 U.S.C. 111) Plant Patent (35 U.S.C. 161) Exclusions Products of nature Products of nature, edible tuber-propagated plants New matter No New information may be added as long as it is drawn to the same plant as claimed Invention must be novel, non-obvious Yes

Utility v. Plant Patents Requirement or Attribute Utility Patent (35 U.S.C. 111) Plant Patent (35 U.S.C. 161) Invention must be “enabled” Yes No Deposit of biological material required Yes, if not enabled by other means Variety name required

Thanks 1638 1661 Stuart Baum Phuong Bui Cynthia Collins David Fox Georgia Helmer Medina Ibrahim Russell Kallis David Kruse Ann Kubelik Vinod Kumar Beth McElwain Ashwin Mehta Brent Page Keith Robinson Cathy Worley Li Zheng 1661 Kent Bell Wendy Haas June Hwu Louanne Krawczewicz-Myers Howard Locker Susan McCormick-Ewoldt Annette Para